Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, develops antibody-based therapeutics for the treatment of various human diseases in the United States. The company's lead product candidate, tovecimig,...
Q1 2026
May 5, 2026
FY 2025
Mar 5, 2026
Q4 2025
Q3 2025
Nov 5, 2025
Q2 2025
Aug 11, 2025